A Columbia University researcher will become the next dean of the School of Medicine at the Medical College of Georgia after a lengthy nationwide search, MCG President Daniel W. Rahn said Thursday.
David Mark Stern, who will also serve as senior vice president for clinical activities, is expected to join MCG by April, Dr. Rahn said. A formal announcement was planned for today.
"I am extremely pleased. I think that we are very fortunate to have him accept the offer to become the new dean and senior VP," Dr. Rahn said.
The choice still must be ratified by the University System of Georgia Board of Regents.
Dr. Stern was out of his office in New York City and did not return a message Thursday. He is currently the chief of the Division of Surgical Science and director of the Center for Vascular and Lung Pathobiology at Columbia. He is a hematologist and the director of the college's Juvenile Diabetes Research Foundation Center on the Vascular Complications of Diabetes. He says he has an interest in a broad range of other diseases, such as cancer and neurodegenerative diseases. Dr. Stern holds nine patents from his work.
"His accomplishments as a physician/scientist are a great asset to his role as dean here," Dr. Rahn said.
Dr. Stern was one of three unranked finalists presented to Dr. Rahn, and he stood out in "his strong background in the development of new research programs," said search committee Chairman Joseph Hobbs, the chairman of the Department of Family Medicine at MCG. "I got the sense that he's aggressive, he's very forward-thinking, and knows how to go after resources to get the job done."
Reach Tom Corwin at (706) 823-3213 or email@example.com.